Page 3 - Nasdaq Aqst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq aqst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Aqst Today - Breaking & Trending Today

Aquestive Therapeutics Reaffirms Timeline and Pathway for

WARREN, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to solve. ....

Daniel Barber , Stephanie Carrington , Aquestive Therapeutics Inc , Drug Administration , Exchange Commission , Chief Executive Officer , Private Securities Litigation Reform Act , Sublingual Film , Annual Report , Quarterly Reports , Current Reports , Aquestive Therapeutics , Nasdaq Aqst , Aquestive Therapeutics ,

Aquestive Therapeutics (AQST) Scheduled to Post Quarterly Earnings on Tuesday

Aquestive Therapeutics (NASDAQ:AQST – Get Rating) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 2nd. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Aquestive Therapeutics has set its FY 2023 guidance at EPS.Parties that are interested in registering for the company’s conference […] ....

Geode Capital Management , Aquestive Therapeutics Company Profile , Renaissance Technologies , Aquestive Therapeutics Inc , Aquestive Therapeutics , Get Rating , Street Corp , Capital Management , Aquestive Therapeutics Daily , Nasdaq Aqst ,

Aquestive Therapeutics, Inc. (NASDAQ:AQST) to Post Q1 2023 Earnings of $0.05 Per Share, Oppenheimer Forecasts

Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Rating) – Research analysts at Oppenheimer upped their Q1 2023 EPS estimates for shares of Aquestive Therapeutics in a note issued to investors on Thursday, March 9th. Oppenheimer analyst F. Brisebois now forecasts that the company will post earnings of $0.05 per share for the quarter, up from their […] ....

Geode Capital Management , Renaissance Technologies , Aquestive Therapeutics Inc , Aquestive Therapeutics , Get Rating , Aquestive Therapeutic , Street Corp , Capital Management , Aquestive Therapeutics Daily , Nasdaq Aqst , Earnings Estimates , Oppenheimer Holdings Inc ,

Aquestive Therapeutics Announces Publication of Crossover

Peer-reviewed data indicates that food significantly decreases and delays the absorption of diazepam dosed via nasal spray. ....

United States , New Jersey , Stephanie Carrington , Us Food Drug Administration , Securities Exchange Commission , Drug Administration , Aquestive Therapeutics Inc , New Drug Application , Buccal Film , Two Treatment Crossover Study , Diazepam Nasal Spray , Healthy Adult , Private Securities Litigation Reform Act , United States Food , Annual Report , Quarterly Reports , Current Reports , Securities Exchange , Aquestive Therapeutics , Nasdaq Aqst , Aquestive Therapeutics ,

Aquestive Therapeutics to Present Positive Data from

WARREN, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing current standards of care. ....

United States , Rutgers University , New Jersey , Ken Truitt , Holly Ponichtera , John Oppenheimer , Stephanie Carrington , Securities Exchange Commission , Drug Administration , Rutgers University School Of Medicine , Aquestive Therapeutics Inc , American College Of Allergy Asthma , American College , Allergy Asthma , Annual Scientific Meeting , Distinguished Industry Oral Abstract , Chief Medical , Pharmacokinetics Study , Epinephrine Sublingual Film , Dosage Selection , Distinguished Industry Oral , Presentation Time , University School , Minimal Impact , Sublingual Film Using , Novel Prodrug ,